Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation in Leishmania donovani-Infected Macrophages

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.50.5.1788-1797.2006PMID 16641451PMCID PMC1472228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1.

  2005cited by this paper
• Leishmania donovani Affects Antigen Presentation of Macrophage by Disrupting Lipid Rafts1

  2005cited by this paper
• Advances in leishmaniasis.

  2005cited by this paper
• Subversion Mechanisms by Which Leishmania Parasites Can Escape the Host Immune Response: a Signaling Point of View

  2005influential reference
• Lipoteichoic acid induces nuclear factor‐κB activation and nitric oxide synthase expression via phosphatidylinositol 3‐kinase, Akt, and p38 MAPK in RAW 264.7 macrophages

  2005cited by this paper
• Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis.

  2005cited by this paper
• Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing

  2004cited by this paper
• Involvement of 3-Phosphoinositide-dependent Protein Kinase-1 in the MEK/MAPK Signal Transduction Pathway*

  2004cited by this paper
• HaRas activates the NADPH oxidase complex in human neuroblastoma cells via extracellular signal‐regulated kinase 1/2 pathway

  2004cited by this paper
• Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses

  2004cited by this paper
• IL‐4 augments anisomycin‐induced p38 activation via Akt pathway in a follicular dendritic cell (FDC)‐like line

  2003cited by this paper
• Immunosuppression in Hamsters with Progressive Visceral Leishmaniasis Is Associated with an Impairment of Protein Kinase C Activity in Their Lymphocytes That Can Be Partially Reversed by Okadaic Acid or Anti-Transforming Growth Factor β Antibody

  2003cited by this paper
• Participation of protein kinase c β in osteoclast differentiation and function

  2003cited by this paper
• CD40 Signaling Is Impaired in L. major–infected Macrophages and Is Rescued by a p38MAPK Activator Establishing a Host-protective Memory T Cell Response

  2003cited by this paper
• Participation of protein kinase C beta in osteoclast differentiation and function.

  2003cited by this paper
• Involvement of the extracellular signal regulated kinase pathway in hydrocarbon-induced reactive oxygen species formation in human neutrophil granulocytes.

  2003cited by this paper
• Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells

  2003cited by this paper
• Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.

  2002cited by this paper
• A phagosome of one's own: a microbial guide to life in the macrophage.

  2002cited by this paper
• Lysophosphatidylcholine Inhibits Insulin-Induced Akt Activation Through Protein Kinase C-&agr; in Vascular Smooth Muscle Cells

  2002influential reference
• Anticancer Activity of Sodium Stibogluconate in Synergy with IFNs1

  2002cited by this paper
• Activities of Hexadecylphosphocholine (Miltefosine), AmBisome, and Sodium Stibogluconate (Pentostam) againstLeishmania donovani in Immunodeficient scidMice

  2001cited by this paper
• Phosphoinositide 3-kinase signalling pathways.

  2001influential reference
• Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38*

  2001cited by this paper
• Sodium Stibogluconate Is a Potent Inhibitor of Protein Tyrosine Phosphatases and Augments Cytokine Responses in Hemopoietic Cell Lines1

  2001cited by this paper
• Endogenous IL‐4 is necessary for effective drug therapy against visceral leishmaniasis

  2000cited by this paper
• Sodium Stibogluconate (Pentostam) Potentiates Oxidant Production in Murine Visceral Leishmaniasis and in Human Blood

  2000cited by this paper
• Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment

  2000cited by this paper
• Roles of Endogenous Gamma Interferon and Macrophage Microbicidal Mechanisms in Host Response to Chemotherapy in Experimental Visceral Leishmaniasis

  2000cited by this paper
• Leishmania donovani promastigotes evade the activation of mitogen‐activated protein kinases p38, c‐Jun N‐terminal kinase, and extracellular signal‐regulated kinase‐1/2 during infection of naive macrophages

  2000cited by this paper
• Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis.

  2000influential reference
• Protein kinase C-alpha participates in FcgammaR-mediated phagocytosis in macrophages.

  2000cited by this paper
• SHP-1 Regulates Lck-induced Phosphatidylinositol 3-Kinase Phosphorylation and Activity*

  1999cited by this paper
• The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls

  1999cited by this paper
• Kala-Azar as an AIDS-Related Opportunistic Infection

  1999cited by this paper
• Leishmania‐induced increases in activation of macrophage SHP‐1 tyrosine phosphatase are associated with impaired IFN‐γ‐triggered JAK2 activation

  1999cited by this paper
• Therapeutic and prophylactic uses of protein A in the control of Leishmania donovani infection in experimental animals.

  1999cited by this paper
• Macrophage Microbicidal Mechanisms In Vivo: Reactive Nitrogen versus Oxygen Intermediates in the Killing of Intracellular Visceral Leishmania donovani

  1999cited by this paper
• Leishmaniasis.

  1999cited by this paper
• Mechanisms of macrophage stimulation through CD8: macrophage CD8alpha and CD8beta induce nitric oxide production and associated killing of the parasite Leishmania major.

  1998cited by this paper
• Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase*

  1998cited by this paper
• Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1.

  1998influential reference
• Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production

  1997cited by this paper
• In vitro antileishmanial properties of tri- and pentavalent antimonial preparations

  1995cited by this paper
• Immunobiological Studies on Experimental Visceral Leishmaniasis IV. Kinetics of Evolution of Disease‐Promoting Versus Host‐Protective Cells of Monocyte‐Macrophage Lineage and their Characterization

  1995cited by this paper
• Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.

  1994cited by this paper
• Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B.

  1994cited by this paper
• Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses

  1994cited by this paper
• [14] Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB

  1994cited by this paper
• Role and effect of IL-2 in experimental visceral leishmaniasis.

  1993cited by this paper
• Immunobiological studies on experimental visceral leishmaniasis I. Changes in lymphoid organs and their possible role in pathogenesis

  1991cited by this paper
• Visceral leishmaniasis: resistance to reinfection in the liver following chemotherapy in the BALB/c mouse.

  1989cited by this paper
• Chemotherapy of antimonial compounds in kala-azar infection. Part I. By U. N. Brahmachari, 1922.

  1989cited by this paper
• Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.

  1989cited by this paper
• Chemotherapy of antimonial compounds in kala-azar infection. Part I. By U. N. Brahmachari, 1922.

  1989cited by this paper
• Chemotherapy of antimonial compounds in kala-azar infection. Part IV. Further observations on the therapeutic values of urea stibamine. By U.N. Brahmachari, 1922.

  1989cited by this paper
• Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony.

  1988cited by this paper
• Visceral leishmaniasis in immunocompromised hosts.

  1987cited by this paper
• Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

  1982cited by this paper
• An in vitro model for investigation of chemotherapeutic agents in leishmaniasis.

  1980cited by this paper

• Immunosuppressant activity and morphological changes in Leishmania amazonensis treated with extracts from seeds of Lonchocarpus cultratus

  2026cites this paper
• Identification of CβS and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by gene expression profiling

  2025cites this paper
• The effect of long-term administration of meglumine antimoniate on the morphometry and histopathology of testicular tissue in mice

  2025cites this paper
• Interplay of human macrophage response and natural resistance of infection by L. (V.) panamensis to pentavalent antimony

  2025cites this paper
• Unveiling the role of serine o-acetyltransferase in drug resistance and oxidative stress tolerance in Leishmania donovani through the regulation of thiol-based redox metabolism.

  2024cites this paper
• Antimony resistance and gene expression in Leishmania: spotlight on molecular and proteomic aspects

  2023cites this paper
• The paradigm of intracellular parasite survival and drug resistance in leishmanial parasite through genome plasticity and epigenetics: Perception and future perspective

  2023cites this paper
• High Selectivity of 8-Hydroxyquinoline on Leishmania (Leishmania) and Leishmania (Viannia) Species Correlates with a Potent Therapeutic Activity In Vivo

  2023cites this paper
• Unveiling drug-tolerant and persister-like cells in Leishmania braziliensis lines derived from patients with cutaneous leishmaniasis

  2023cites this paper
• TDP1 knockout Leishmania donovani accumulate topoisomerase 1‐linked DNA damage and are hypersensitive to clinically used antileishmanial drugs

  2022cites this paper
• Cardiovascular Effects of Environmental Metal Antimony: Redox Dyshomeostasis as the Key Pathogenic Driver

  2022cites this paper
• Perceptions on therapeutic modalities regarding the virulence and immunity of cutaneous leishmaniasis

  2021cites this paper
• Relationships between urinary antimony concentrations and depressive symptoms in adults

  2021cites this paper
• Activity of Anti-Microbial Peptides (AMPs) against Leishmania and Other Parasites: An Overview

  2021cites this paper
• Chalcone-rich extracts from Lonchocarpus cultratus roots present in vitro leishmanicidal and immunomodulatory activity.

  2021cites this paper
• Why do few drug delivery systems to combat neglected tropical diseases reach the market? An analysis from the technology’s stages

  2021cites this paper
• A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity

  2021cites this paper
• Therapeutic Modalities in Post Kala-azar Dermal Leishmaniasis: A Systematic Review of the Effectiveness and Safety of the Treatment Options

  2021cites this paper
• Epigallocathechin-O-3-Gallate Inhibits Trypanothione Reductase of Leishmania infantum, Causing Alterations in Redox Balance and Leading to Parasite Death

  2021cites this paper
• Development of new combination anti-leishmanial complexes: Triphenyl Sb(V) mono-hydroxy mono-quinolinolates.

  2021cites this paper
• LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling.

  2021cites this paper
• Combination of Mycobacterium indicus pranii and Heat-Induced Promastigotes Cures Drug-Resistant Leishmania Infection: Critical Role of Interleukin-6-Producing Classical Dendritic Cells

  2020cites this paper
• Antimony and bismuth as antimicrobial agents

  2020cites this paper
• Biogenic metal nanoparticles as a potential class of antileishmanial agents: mechanisms and molecular targets.

  2020cites this paper
• El tratamiento intralesional de Leishmaniasis cutánea es seguro frente al riesgo de complicaciones mucosas?

  2020cites this paper
• Can We Harness Immune Responses to Improve Drug Treatment in Leishmaniasis?

  2020cites this paper
• Outwitting an old neglected nemesis: A review on leveraging integrated data-driven approaches to aid in unraveling of leishmanicides of therapeutic potential.

  2020cites this paper
• Immunophenotyping of Peripheral Blood, Lymph Node, and Bone Marrow T Lymphocytes During Canine Leishmaniosis and the Impact of Antileishmanial Chemotherapy

  2020cites this paper
• Oxidative Stress Inducers as Potential Anti-Leishmanial Agents

  2019cites this paper
• Exploring Endoperoxides as Leishmanicidal Compounds

  2019cites this paper
• Oxidative Stress and Antioxidants in Host Defense in Leishmaniasis

  2019cites this paper
• Role of Reactive Oxygen Species in Infection by the Intracellular Leishmania Parasites

  2019cites this paper
• “Cheaper and better”: Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia

  2019cites this paper
• Leishmanicidal therapy targeted to parasite proteases

  2019cites this paper
• Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK1R) agonist GR73632 evokes vomiting in the least shrew (Cryptotis parva)

  2019cites this paper
• Novel synthesis of ultra-fine Sb2O3 nanocubes using plant extract.

  2019cites this paper
• Palladium(ii) and platinum(ii) complexes of glyoxalbis(N-aryl)osazone: molecular and electronic structures, anti-microbial activities and DNA-binding study

  2019cites this paper
• Neuroprotective effect of (-)-tetrahydropalmatine in Japanese encephalitis virus strain GP-78 infected mouse model.

  2018cites this paper
• Emergence of Leptin in Infection and Immunity: Scope and Challenges in Vaccines Formulation

  2018cites this paper
• Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility

  2018cites this paper
• Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent

  2018cites this paper
• Ascorbic acid reduces the genetic damage caused by miltefosine (hexadecylphosphocholine) in animals infected by Leishmania (Leishamnia) infantum without decreasing its antileishmanial activity

  2018cites this paper
• Cytosolic tryparedoxin of Leishmania donovani modulates host immune response in visceral leishmaniasis

  2018cites this paper
• The leishmanicidal activity of artemisinin is mediated by cleavage of the endoperoxide bridge and mitochondrial dysfunction

  2018cites this paper
• Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages

  2018cites this paper
• Immunomodulatory therapy of visceral leishmaniasis in HIV coinfected patients

  2018cites this paper
• Chemotherapy and Experimental Models of Visceral Leishmaniasis

  2018cites this paper
• Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients

  2018influential citation
• Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress

  2017cites this paper
• In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum

  2017cites this paper
• Snapshot profiling of anti-leishmanial potency of lead compounds and drug candidates 1 against intracellular L. donovani amastigotes with focus on human derived host cells

  2017cites this paper
• Knockdown of Host Antioxidant Defense Genes Enhances the Effect of Glucantime on Intracellular Leishmania braziliensis in Human Macrophages

  2017cites this paper
• Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs

  2017cites this paper
• Functional Involvement of Leishmania donovani Tryparedoxin Peroxidases during Infection and Drug Treatment

  2017cites this paper
• Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb/c mice

  2017cites this paper
• Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs.

  2017cites this paper
• Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype

  2017cites this paper
• Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopes

  2017influential citation
• Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice

  2017cites this paper
• Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum

  2017cites this paper
• Molecular identification of an old clinical isolate of Indian Kala-azar

  2017cites this paper
• Snapshot Profiling of the Antileishmanial Potency of Lead Compounds and Drug Candidates against Intracellular Leishmania donovani Amastigotes, with a Focus on Human-Derived Host Cells

  2017cites this paper
• In vivo/In vitro immune responses to L. major isolates from patients with no clinical response to Glucantime

  2016cites this paper
• The Role of Metabolomics in Antiparasitic Drug Discovery

  2016cites this paper
• Redox-Active Metal Complexes in Trypanosomatids

  2016cites this paper
• The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis

  2016cites this paper
• Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective

  2016influential citation
• Visceral leishmaniasis: Revisiting current treatments and approaches for future discoveries.

  2016cites this paper
• Plasticity of the Leishmania genome leading to gene copy number variations and drug resistance

  2016cites this paper
• Urinary antimony and leukocyte telomere length: An analysis of NHANES 1999-2002.

  2016cites this paper
• Leptin induces the phagocytosis and protective immune response in Leishmania donovani infected THP-1 cell line and human PBMCs.

  2016cites this paper
• Antimony resistant but not antimony sensitive Leishmania donovani upregulates host IL-10 by recruiting NF-B at specific site of IL-10 promoter. Introduction Kala-azar or visceral leishmaniasis (VL), caused by the protozoan parasite Leishmania donovani(LD),

  2016cites this paper
• Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages

  2016cites this paper
• Leishmania mexicana promastigotes down regulate JNK and p-38 MAPK activation: Role in the inhibition of camptothecin-induced apoptosis of monocyte-derived dendritic cells.

  2016cites this paper
• A Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum and Their Properties

  2016cites this paper
• A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum

  2016cites this paper
• Epidemiological studies on zoonotic leishmaniasis and new trials for studying the effect of melatonin on the parasite

  2015cites this paper
• Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis.

  2015cites this paper
• Anti- and prooxidant activity of triphenylantimony(V) catecholates derived from alkyl gallates

  2015cites this paper
• Leishmania mexicana amastigotes inhibit p38 and JNK and activate PI3K/AKT: role in the inhibition of apoptosis of dendritic cells

  2015cites this paper
• Treatment of leishmaniasis: a review and assessment of recent research.

  2015cites this paper
• Neurological disease in human and canine leishmaniasis – clinical features and immunopathogenesis

  2015cites this paper
• Ex Vivo Host and Parasite Response to Antileishmanial Drugs and Immunomodulators

  2015cites this paper
• Upregulation of Cysteine Synthase and Cystathionine β-Synthase Contributes to Leishmania braziliensis Survival under Oxidative Stress

  2015cites this paper
• Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum

  2015cites this paper
• Acid heteropolysaccharides with potent antileishmanial effects.

  2015cites this paper
• Antileishmanial Effect of 18β-Glycyrrhetinic Acid Is Mediated by Toll-Like Receptor-Dependent Canonical and Noncanonical p38 Activation

  2015cites this paper
• Soy isoflavones have antimutagenic activity on DNA damage induced by the antileishmanial Glucantime (meglumine antimoniate)

  2015cites this paper
• Phosphoproteomic analysis of wild‐type and antimony‐resistant Leishmania braziliensis lines by 2D‐DIGE technology

  2015cites this paper
• Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.

  2015cites this paper
• Leishmania braziliensis survival under oxidative stress 2 Running title : Leishmania braziliensis resistance to oxidative stress 3

  2015cites this paper
• Synthesis and antiradical activity of new triphenylantimony(V) catechlolates derived from alkyl gallates

  2015cites this paper
• Experimental Resistance to Drug Combinations in Leishmania donovani: Metabolic and Phenotypic Adaptations

  2015cites this paper
• Further characterization of a secreted lipase from the human pathogen Leishmania donovani by determining the effect of various metal ions on its enzymatic activity.

  2014cites this paper
• Antimony Resistance Clinical Isolates and Its Association with Nuclear Antigen of Leishmania donovani Characterization of the Proliferating Cell

  2014cites this paper
• The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of MAP kinases through specific protein kinase C isoforms

  2014cites this paper
• Characterization of the Proliferating Cell Nuclear Antigen of Leishmania donovani Clinical Isolates and Its Association with Antimony Resistance

  2014cites this paper
• Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis.

  2014cites this paper
• Saha Institute of Nuclear Physics — Its Past and the Present

  2014cites this paper
• The influence of triphenylantimony(V) catecholate and its spiroendoperoxide on lipid peroxidation

  2014cites this paper